Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1

Details for Australian Patent Application No. 2007208515 (hide)

Owner Merck & Co., Inc.

Inventors Gu, Xin; Waddell, Sherman T.; Kevin, Nancy J.

Agent Spruson & Ferguson

Pub. Number AU-A-2007208515

PCT Pub. Number WO2007/087150

Priority 60/759,178 13.01.06 US

Filing date 9 January 2007

Wipo publication date 2 August 2007

International Classifications

C07D 487/02 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

Event Publications

10 July 2008 PCT application entered the National Phase

  PCT publication WO2007/087150 Priority application(s): WO2007/087150

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

2 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007208516-Combination of ache inhibitor and 5-HTS antagonist for the treatment of cognitive dysfunction

2007208511-Hernia patch frame